Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinil Pharmaceutical is a South Korean pharmaceutical company established in 1971 that specializes in the development and manufacturing of a wide range of medicinal products. The company is particularly recognized for its expertise in transdermal drug delivery systems, producing popular medicated patches and plasters for pain relief. Beyond topicals, Sinil offers an extensive portfolio of over 100 products, including treatments for circulatory, digestive, and endocrine systems. It operates as both a branded manufacturer and a contract manufacturing organization (CMO) for other domestic and international firms. Sinil Pharmaceutical is publicly traded on the KOSDAQ exchange and maintains a strong presence in the Korean domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SINIL PHARMACEUTICAL.